menu
    • menu

    Company profile for Hoth Therapeutics

    NEW Drugs in Dev: 17
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Hoth Therapeutics is a development stage biopharmaceutical company focused on proprietary therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema. To treat indications impacting more than 32 million Americans, Hoth is working to develop and commercialize the BioLexa™ Platform, a proprietary, patented, drug compound platform developed at the University of Cincinnati. The BioLexa Pl...
    Hoth Therapeutics is a development stage biopharmaceutical company focused on proprietary therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema. To treat indications impacting more than 32 million Americans, Hoth is working to develop and commercialize the BioLexa™ Platform, a proprietary, patented, drug compound platform developed at the University of Cincinnati. The BioLexa Platform has achieved positive results at preclinical studies conducted at the University of Miami.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Hoth TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Rockefeller Plaza Suite 1039 New York, New York 10020
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://hoththerapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hoth Therapeutics Reports Positive HT-VA CRADA Data
    Hoth Therapeutics Reports Positive HT-VA CRADA Data

    13 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hoth-therapeutics-hoth-reports-positive-ht-va-crada-data-gdnf-reprograms-liver-fat-metabolism-shuts-down-fat-creation-gene-and-activates-fat-burning-pathways-outperforming-semaglutide-302740965.html

    PR NEWSWIRE
    13 Apr 2026
    Share Share
    Hoth Therapeutics Closes $2.0M Registered Direct Offering
    Hoth Therapeutics Closes $2.0M Registered Direct Offering

    02 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hoth-therapeutics-announces-closing-of-2-0-million-registered-direct-offering-302733218.html

    PR NEWSWIRE
    02 Apr 2026
    Share Share
    HT-001 Meets Primary Endpoint; Trial Expanded in Hungary
    HT-001 Meets Primary Endpoint; Trial Expanded in Hungary

    01 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hungary-approves-trial-expansion-as-ht-001-meets-primary-endpoint-in-interim-analysis-with-patients-reaching-ariga-1-by-week-six-302731156.html

    PR NEWSWIRE
    01 Apr 2026
    Share Share
    Hoth Therapeutics Gets Chinese Patent for Cancer Cell Targeting
    Hoth Therapeutics Gets Chinese Patent for Cancer Cell Targeting

    31 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hoth-therapeutics-announces-issuance-of-chinese-patent-for-cancer-celltargeting-technology-302729593.html

    PR NEWSWIRE
    31 Mar 2026
    Share Share
    Hoth Pharma Uses Openclaw AI To Speed Up Drug Discovery
    Hoth Pharma Uses Openclaw AI To Speed Up Drug Discovery

    26 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hoth-therapeutics-deploys-openclaw-ai-platform-to-accelerate-drug-discovery-302725506.html

    PR NEWSWIRE
    26 Mar 2026
    Share Share
    Hoth Therapeutics Reveals Strong HT-001 Data In EGFR Therapy
    Hoth Therapeutics Reveals Strong HT-001 Data In EGFR Therapy

    24 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hoth-therapeutics-reports-positive-ht-001-pk-safety-and-clinical-activity-data-in-cancer-patients-with-egfr-therapyassociated-skin-toxicities-showing-77-increase-in-drug-exposure-and-minimal-systemic-absorption-302722341.html

    PR NEWSWIRE
    24 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search